The Magnificent Seven stocks have been a huge source of gains for the S&P 500. Without the cohort of tech titans, I think ...

She has conducted cutting-edge research across academia and industry for over a decade, pioneering new AI algorithms that simulate physical systems with unprecedented speed and accuracy—in some ...

versus using AI, laboratory work, or clinical research methods alone. Moving forward, Fajgenbaum and his team are gearing up to launch a clinical trial this year of the effectiveness of another ...

Separately, Rakovina Therapeutics expects to receive the first synthesized drug candidates from its second AI-driven drug discovery program targeting ATR. AI-derived drug candidates are first ...

In this special issue in ACS Medicinal Chemistry Letters, you will find a collection of 14 publications which highlight significant successes made with artificial intelligence/machine learning (AI/ML ...

Drug discovery firm Exscientia has claimed a world first after announcing that the first precision engineered drug generated by artificial intelligence (AI) is entering clinical trials.

Global AI Drug Discovery Center, College of Pharmacy, and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea ...

Drug discovery has long been plagued by high costs, inefficiencies and high failure rates. Therefore, many companies are now adopting AI to accelerate innovation and improve outcomes across every ...